tirzepatide alcohol use disorder The latest AAAP podcast episode is live! ποΈ Could medications like semaglutide and become a new tool in treating Disorder? In this episode, hosts Danae DiRocco, MD, MPH and GLP-1 medications get at the
Description
Competing interests None

S.MahmoodS.Hamed AlmurisiS.Reddy VenugopalJ.Rebhi HillesA.AzmanaM.et al (2020)

Further clinical research is necessary to fully understand the potential benefits and risks associated with prolonged microdosing of tirzepatide

Free, no spam, unsubscribe whenever

Compared to Phentermine/Topiramate, Tirzepatide showed an observed association with reduced incidence only for dry eye disease (HR 0.29, 95% CI: 0.150.57, p = 1.3 10 4 ), with other outcomes showing non-significant trends, including cataracts (HR 0.76, 95% CI: 0.381.52, p = 0.433)

Impairment is the clinical threshold for when anxiety warrants treatment intervention
